Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis
US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.
You may also be interested in...
The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.
Tyto Care will use the proceeds to expand its telehealth and remote monitoring solution to the US, Europe, and Asia, and add AI capabilities.
Eko Raises $65M In Series C Round To Expand AI-Based Digital Stethoscope For At-Home Patient Monitoring
Eko is banking on the growing telehealth market and reimbursement to expand its cardiac care platform.